Vernieri, F., Brunelli, N., Marcosano, M., Aurilia, C., Egeo, G., Lovati, C., et al. (2022). Maintenance of response and predictive factors of one-year GalcanezumAb treatment in Real Life migraine patients in ITaly: the multicenter prospective cohort GARLIT study. EUROPEAN JOURNAL OF NEUROLOGY [10.1111/ene.15563].
Maintenance of response and predictive factors of one-year GalcanezumAb treatment in Real Life migraine patients in ITaly: the multicenter prospective cohort GARLIT study
Albanese M;
2022-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Maintenance of response EJN Sep 2022.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.34 MB
Formato
Adobe PDF
|
1.34 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
